nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—SIK1—parotid gland—salivary gland cancer	0.00807	0.0853	CbGeAlD
Dabrafenib—NEK11—lymph node—salivary gland cancer	0.00791	0.0836	CbGeAlD
Dabrafenib—RAF1—neck—salivary gland cancer	0.00788	0.0833	CbGeAlD
Dabrafenib—SIK1—saliva-secreting gland—salivary gland cancer	0.00772	0.0817	CbGeAlD
Dabrafenib—SIK1—connective tissue—salivary gland cancer	0.0071	0.075	CbGeAlD
Dabrafenib—RAF1—parotid gland—salivary gland cancer	0.00642	0.0679	CbGeAlD
Dabrafenib—RAF1—saliva-secreting gland—salivary gland cancer	0.00615	0.065	CbGeAlD
Dabrafenib—LIMK1—lymph node—salivary gland cancer	0.00566	0.0599	CbGeAlD
Dabrafenib—RAF1—connective tissue—salivary gland cancer	0.00565	0.0597	CbGeAlD
Dabrafenib—RAF1—epithelium—salivary gland cancer	0.00536	0.0567	CbGeAlD
Dabrafenib—SIK1—lymphoid tissue—salivary gland cancer	0.00519	0.0549	CbGeAlD
Dabrafenib—RAF1—lymphoid tissue—salivary gland cancer	0.00413	0.0437	CbGeAlD
Dabrafenib—BRAF—lymph node—salivary gland cancer	0.0035	0.037	CbGeAlD
Dabrafenib—SIK1—lymph node—salivary gland cancer	0.00293	0.031	CbGeAlD
Dabrafenib—ABCG2—parotid gland—salivary gland cancer	0.00266	0.0281	CbGeAlD
Dabrafenib—ABCG2—saliva-secreting gland—salivary gland cancer	0.00254	0.0269	CbGeAlD
Dabrafenib—RAF1—lymph node—salivary gland cancer	0.00233	0.0246	CbGeAlD
Dabrafenib—ABCB1—epithelium—salivary gland cancer	0.00109	0.0116	CbGeAlD
Dabrafenib—ABCG2—lymph node—salivary gland cancer	0.000964	0.0102	CbGeAlD
Dabrafenib—ABCB1—lymphoid tissue—salivary gland cancer	0.000843	0.00891	CbGeAlD
Dabrafenib—ABCB1—lymph node—salivary gland cancer	0.000475	0.00503	CbGeAlD
Dabrafenib—BRAF—Focal Adhesion—HRAS—salivary gland cancer	0.000295	0.000326	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—NUP62—salivary gland cancer	0.000293	0.000324	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000293	0.000324	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—VCAN—salivary gland cancer	0.000291	0.000321	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TP53—salivary gland cancer	0.000285	0.000315	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—HRAS—salivary gland cancer	0.000285	0.000315	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—FOXO3—salivary gland cancer	0.000285	0.000315	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PHGDH—salivary gland cancer	0.000284	0.000314	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000283	0.000313	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MAML3—salivary gland cancer	0.000283	0.000312	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FGF16—salivary gland cancer	0.000282	0.000311	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.00028	0.000309	CbGpPWpGaD
Dabrafenib—BRAF—Disease—JAG1—salivary gland cancer	0.000279	0.000308	CbGpPWpGaD
Dabrafenib—BRAF—Disease—FGFR4—salivary gland cancer	0.000278	0.000307	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000276	0.000305	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—HRAS—salivary gland cancer	0.000275	0.000303	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MAP2K2—salivary gland cancer	0.000274	0.000303	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ST3GAL4—salivary gland cancer	0.000273	0.000302	CbGpPWpGaD
Dabrafenib—BRAF—Disease—FBXW7—salivary gland cancer	0.000273	0.000302	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NUP62—salivary gland cancer	0.00027	0.000299	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000268	0.000296	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.000268	0.000296	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000265	0.000293	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	0.000264	0.000292	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000264	0.000291	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FGF16—salivary gland cancer	0.000263	0.000291	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PHGDH—salivary gland cancer	0.000263	0.00029	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—PIK3CA—salivary gland cancer	0.000262	0.000289	CbGpPWpGaD
Dabrafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—salivary gland cancer	0.00026	0.000288	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FGF16—salivary gland cancer	0.00026	0.000287	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000259	0.000286	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000255	0.000282	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—HRAS—salivary gland cancer	0.000255	0.000281	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	0.000253	0.00028	CbGpPWpGaD
Dabrafenib—RAF1—Insulin Signaling—PIK3CA—salivary gland cancer	0.000253	0.000279	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MC3R—salivary gland cancer	0.000252	0.000278	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000252	0.000278	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—PIK3CA—salivary gland cancer	0.00025	0.000277	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NUP62—salivary gland cancer	0.00025	0.000276	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000249	0.000275	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AQP1—salivary gland cancer	0.000248	0.000274	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—PIK3CA—salivary gland cancer	0.000248	0.000274	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000248	0.000274	CbGpPWpGaD
Dabrafenib—RAF1—Disease—VCAN—salivary gland cancer	0.000248	0.000273	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—HRAS—salivary gland cancer	0.000244	0.000269	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000243	0.000268	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000243	0.000268	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—HRAS—salivary gland cancer	0.000242	0.000268	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MAP2K2—salivary gland cancer	0.000242	0.000268	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000236	0.000261	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000235	0.00026	CbGpPWpGaD
Dabrafenib—RAF1—Insulin Signaling—HRAS—salivary gland cancer	0.000234	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—PIK3CA—salivary gland cancer	0.000233	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000233	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000233	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—HRAS—salivary gland cancer	0.000233	0.000257	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.000232	0.000256	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—HRAS—salivary gland cancer	0.000232	0.000256	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000231	0.000255	CbGpPWpGaD
Dabrafenib—BRAF—Disease—FOXO3—salivary gland cancer	0.000231	0.000255	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—HRAS—salivary gland cancer	0.000231	0.000255	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.00023	0.000254	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AQP1—salivary gland cancer	0.00023	0.000254	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—PIK3CA—salivary gland cancer	0.00023	0.000254	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—HRAS—salivary gland cancer	0.000229	0.000253	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000229	0.000253	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MAML2—salivary gland cancer	0.000229	0.000253	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000228	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MAML2—salivary gland cancer	0.000226	0.00025	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—PTEN—salivary gland cancer	0.000225	0.000249	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NOTCH1—salivary gland cancer	0.000225	0.000248	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—PIK3CA—salivary gland cancer	0.00022	0.000243	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DTX4—salivary gland cancer	0.00022	0.000243	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00022	0.000242	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—HRAS—salivary gland cancer	0.000217	0.000239	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—PTEN—salivary gland cancer	0.000216	0.000239	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—HRAS—salivary gland cancer	0.000216	0.000238	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000216	0.000238	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000216	0.000238	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MARCKS—salivary gland cancer	0.000215	0.000238	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000215	0.000237	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—HRAS—salivary gland cancer	0.000214	0.000236	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—HRAS—salivary gland cancer	0.000213	0.000235	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000212	0.000235	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000212	0.000234	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—HRAS—salivary gland cancer	0.000211	0.000233	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00021	0.000232	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FGFR4—salivary gland cancer	0.000208	0.00023	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000207	0.000228	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—EP300—salivary gland cancer	0.000206	0.000228	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000205	0.000227	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FBXW7—salivary gland cancer	0.000205	0.000226	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—HRAS—salivary gland cancer	0.000204	0.000225	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CREBBP—salivary gland cancer	0.000204	0.000225	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PYGB—salivary gland cancer	0.0002	0.000221	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—CREBBP—salivary gland cancer	0.0002	0.000221	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.0002	0.000221	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NUP62—salivary gland cancer	0.000197	0.000217	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000196	0.000216	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—JAG1—salivary gland cancer	0.000195	0.000216	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000195	0.000216	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—VCAN—salivary gland cancer	0.000195	0.000216	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FGFR4—salivary gland cancer	0.000195	0.000215	CbGpPWpGaD
Dabrafenib—RAF1—Disease—JAG1—salivary gland cancer	0.000193	0.000213	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FGFR4—salivary gland cancer	0.000192	0.000212	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FBXW7—salivary gland cancer	0.000191	0.000211	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000191	0.000211	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FBXW7—salivary gland cancer	0.000189	0.000209	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MAP2K2—salivary gland cancer	0.000188	0.000208	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000188	0.000207	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000185	0.000204	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NUP62—salivary gland cancer	0.000182	0.000201	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGF16—salivary gland cancer	0.000182	0.000201	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000182	0.000201	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—VCAN—salivary gland cancer	0.000181	0.0002	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CREBBP—salivary gland cancer	0.00018	0.000199	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000179	0.000198	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000174	0.000193	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000174	0.000192	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000173	0.000191	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—FOXO3—salivary gland cancer	0.000173	0.000191	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CDH1—salivary gland cancer	0.000172	0.000189	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000171	0.000189	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PHGDH—salivary gland cancer	0.000163	0.00018	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000163	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000162	0.000179	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FOXO3—salivary gland cancer	0.000161	0.000178	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FOXO3—salivary gland cancer	0.00016	0.000176	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—PIK3CA—salivary gland cancer	0.000159	0.000176	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MAML2—salivary gland cancer	0.000158	0.000175	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	0.000157	0.000174	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000154	0.000171	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NOTCH1—salivary gland cancer	0.000154	0.00017	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—PIK3CA—salivary gland cancer	0.000153	0.000169	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000152	0.000168	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000151	0.000167	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—HRAS—salivary gland cancer	0.00015	0.000166	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.00015	0.000165	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—HRAS—salivary gland cancer	0.000147	0.000162	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000147	0.000162	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AQP1—salivary gland cancer	0.000143	0.000158	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000142	0.000157	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000142	0.000157	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HRAS—salivary gland cancer	0.000141	0.000156	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MAP2K2—salivary gland cancer	0.000141	0.000156	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00014	0.000155	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CREBBP—salivary gland cancer	0.00014	0.000154	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EP300—salivary gland cancer	0.000139	0.000153	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000137	0.000151	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—EP300—salivary gland cancer	0.000136	0.00015	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—JAG1—salivary gland cancer	0.000135	0.000149	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGFR4—salivary gland cancer	0.000135	0.000149	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—HRAS—salivary gland cancer	0.000133	0.000147	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FBXW7—salivary gland cancer	0.000132	0.000146	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MAP2K2—salivary gland cancer	0.000132	0.000146	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MAP2K2—salivary gland cancer	0.00013	0.000144	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000129	0.000142	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—PTEN—salivary gland cancer	0.000129	0.000142	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000124	0.000137	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—PTEN—salivary gland cancer	0.000123	0.000136	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EP300—salivary gland cancer	0.000123	0.000135	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000122	0.000135	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000117	0.000129	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000116	0.000128	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CREBBP—salivary gland cancer	0.000114	0.000125	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NUP62—salivary gland cancer	0.000113	0.000125	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—VCAN—salivary gland cancer	0.000112	0.000124	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FOXO3—salivary gland cancer	0.000112	0.000123	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NOTCH1—salivary gland cancer	0.000108	0.000119	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000107	0.000119	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOTCH1—salivary gland cancer	0.000107	0.000118	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CREBBP—salivary gland cancer	0.000105	0.000116	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CDH1—salivary gland cancer	0.000104	0.000115	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000104	0.000114	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—PIK3CA—salivary gland cancer	0.000101	0.000111	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.0001	0.000111	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTEN—salivary gland cancer	9.99e-05	0.00011	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NUP62—salivary gland cancer	9.85e-05	0.000109	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	9.85e-05	0.000109	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CREBBP—salivary gland cancer	9.79e-05	0.000108	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—VCAN—salivary gland cancer	9.78e-05	0.000108	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TP53—salivary gland cancer	9.74e-05	0.000108	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CREBBP—salivary gland cancer	9.68e-05	0.000107	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EP300—salivary gland cancer	9.53e-05	0.000105	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—HRAS—salivary gland cancer	9.5e-05	0.000105	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—HRAS—salivary gland cancer	9.32e-05	0.000103	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MAP2K2—salivary gland cancer	9.12e-05	0.000101	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—PIK3CA—salivary gland cancer	9.07e-05	0.0001	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PHGDH—salivary gland cancer	8.76e-05	9.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—PIK3CA—salivary gland cancer	8.71e-05	9.61e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.64e-05	9.54e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	8.43e-05	9.31e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—HRAS—salivary gland cancer	8.39e-05	9.26e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.16e-05	9.01e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTEN—salivary gland cancer	8.11e-05	8.96e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HRAS—salivary gland cancer	8.05e-05	8.9e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—EP300—salivary gland cancer	7.74e-05	8.55e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AQP1—salivary gland cancer	7.66e-05	8.46e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CREBBP—salivary gland cancer	7.63e-05	8.43e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PTEN—salivary gland cancer	7.48e-05	8.27e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NOTCH1—salivary gland cancer	7.47e-05	8.25e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCND1—salivary gland cancer	7.25e-05	8e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EP300—salivary gland cancer	7.14e-05	7.88e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CREBBP—salivary gland cancer	7.07e-05	7.81e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PIK3CA—salivary gland cancer	7.05e-05	7.78e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.03e-05	7.77e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTEN—salivary gland cancer	6.99e-05	7.72e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTEN—salivary gland cancer	6.91e-05	7.63e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CREBBP—salivary gland cancer	6.78e-05	7.48e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	6.71e-05	7.41e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EP300—salivary gland cancer	6.67e-05	7.37e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EP300—salivary gland cancer	6.59e-05	7.28e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—HRAS—salivary gland cancer	6.52e-05	7.2e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NUP62—salivary gland cancer	6.07e-05	6.71e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—VCAN—salivary gland cancer	6.02e-05	6.65e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—PIK3CA—salivary gland cancer	5.78e-05	6.38e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PIK3CA—salivary gland cancer	5.72e-05	6.32e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTEN—salivary gland cancer	5.45e-05	6.02e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HRAS—salivary gland cancer	5.35e-05	5.91e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PIK3CA—salivary gland cancer	5.28e-05	5.83e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—EP300—salivary gland cancer	5.2e-05	5.74e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTEN—salivary gland cancer	5.05e-05	5.58e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCND1—salivary gland cancer	5.01e-05	5.54e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.96e-05	5.48e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PIK3CA—salivary gland cancer	4.93e-05	5.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HRAS—salivary gland cancer	4.89e-05	5.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PIK3CA—salivary gland cancer	4.87e-05	5.38e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTEN—salivary gland cancer	4.84e-05	5.34e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—EP300—salivary gland cancer	4.81e-05	5.32e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—salivary gland cancer	4.77e-05	5.27e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EP300—salivary gland cancer	4.61e-05	5.1e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HRAS—salivary gland cancer	4.57e-05	5.04e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—HRAS—salivary gland cancer	4.51e-05	4.98e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CREBBP—salivary gland cancer	4.39e-05	4.84e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PIK3CA—salivary gland cancer	3.85e-05	4.25e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CREBBP—salivary gland cancer	3.82e-05	4.22e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PIK3CA—salivary gland cancer	3.56e-05	3.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PIK3CA—salivary gland cancer	3.41e-05	3.77e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—salivary gland cancer	3.3e-05	3.65e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HRAS—salivary gland cancer	3.16e-05	3.49e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTEN—salivary gland cancer	3.13e-05	3.46e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—EP300—salivary gland cancer	2.99e-05	3.3e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTEN—salivary gland cancer	2.73e-05	3.01e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—EP300—salivary gland cancer	2.6e-05	2.87e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CREBBP—salivary gland cancer	2.35e-05	2.6e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	2.21e-05	2.44e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PIK3CA—salivary gland cancer	1.93e-05	2.13e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTEN—salivary gland cancer	1.68e-05	1.86e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EP300—salivary gland cancer	1.6e-05	1.77e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.19e-05	1.31e-05	CbGpPWpGaD
